Achilles Therapeutics plc
ACHL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69,935 | -$71,176 | -$61,099 | -$33,199 |
| Dep. & Amort. | $4,713 | $3,690 | $3,288 | $772 |
| Deferred Tax | $0 | $0 | $159 | $0 |
| Stock-Based Comp. | $6,357 | $7,022 | $6,317 | $2,992 |
| Change in WC | $10,409 | -$5,956 | -$7,931 | $3,004 |
| Other Non-Cash | $7 | $6,885 | -$18 | $1,179 |
| Operating Cash Flow | -$48,449 | -$59,535 | -$59,284 | -$25,252 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,100 | -$7,512 | -$7,634 | -$11,847 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$7,512 | -$7,634 | $0 |
| Investing Cash Flow | -$1,100 | -$7,512 | -$7,634 | -$11,847 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9 | $1 | $160,736 | $114,588 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $160,755 | $113,704 |
| Financing Cash Flow | $9 | $1 | $161 | $113,704 |
| Forex Effect | $7,741 | -$25,935 | -$5,334 | $3,650 |
| Net Chg. in Cash | -$41,799 | -$92,981 | $88,503 | $80,255 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $173,371 | $266,352 | $177,849 | $97,594 |
| End Cash | $131,572 | $173,371 | $266,352 | $177,849 |
| Free Cash Flow | -$49,549 | -$67,047 | -$66,918 | -$37,099 |